27th ISMRM Annual Meeting • 11-16 May 2019 • Montréal, QC, Canada

Educational Course
Diverse Perspectives on Imaging-Based Diagnosis of HCC

Back to Program-at-a-Glance

Diverse Perspectives on Imaging-Based Diagnosis of HCC
Weekday Course

ORGANIZERS: Mustafa Shadi Bashir, Utaroh Motosugi

Monday, 13 May 2019
  16:00 - 18:00

Skill Level: Intermediate to Advanced

Session Number: M-08

Hepatocellular carcinoma (HCC) is a most common primary liver cancer, specifically developing in cirrhotic liver. Imaging has an important role in the management of HCC because biopsy or pathological evaluation is not typically required to make the final diagnosis of HCC; in other words, treatment decisions, e.g. whether or not liver transplantation is performed, can be made only by MRI. Therefore, guidelines/criteria of the diagnosis have been published by certificated organization in the US, Europe, and Asia. Unfortunately, the criteria of the diagnosis in these guidelines are not exactly the same, which confuse the researchers working on liver imaging. In this session, we will try to clarify how and why the imaging-based diagnosis of HCC are different region by region or country by country.

Target Audience
Radiologists and scientists who are interested in clinical liver imaging.

Educational Objectives
As a result of attending this course, participants should be able to:
- Identify clinical needs for imaging-based diagnosis of HCC; and
- Describe and compare and contrast several major criteria for diagnosis of HCC based on MRI.


  Hepatologist's Perspective
Andrew Muir
Kathryn Fowler
  Asian Guidelines
Keitaro Sofue
  European Guidelines
Luigi Grazioli
Back to Program-at-a-Glance   |   Back to Top
The International Society for Magnetic Resonance in Medicine is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.